Advocacy & Policy

The House Energy and Commerce Health Subcommittee held a July 11 hearing on the 340B Drug Pricing Program. The hearing included a review of a recent Government

The U.S. Government Accountability Office (GAO) June 28 released a report that examines how covered entities that participate in the 340B Drug Pricing Program u

The Senate Health, Education, Labor, and Pensions (HELP) Committee June 19 held the third in a series of hearings on the 340B Drug Pricing Program. The hearing

Representative Doris Matsui (D-Calif.) June 12 introduced the Stretching Entity Resources for Vulnerable (SERV) Communities Act (H.R. 6071) to support and expan

The Health Resources and Services Administration (HRSA) June 1 released a final rule delaying the implementation of the 340B Drug Pricing Program ceiling price

The AAMC May 21 submitted a comment letter in response to the Health Services and Resources Administration’s (HRSA) notice to further delay the 340B Drug Pricin

The Senate Health, Education, Labor, and Pension (HELP) Committee May 15 held the second in a series of hearings to examine the 340B Drug Pricing Program [see W

A three-judge panel of the D.C. Circuit May 4 heard arguments in the case challenging Medicare payment cuts to many hospitals in the 340B Drug Pricing Program.

The Health Resources and Services Administration (HRSA) released a proposed rule delaying the implementation of the 340B Drug Pricing Program ceiling price and

The Senate Health, Education, Labor, and Pensions (HELP) Committee March 15 held a hearing entitled “Perspectives on the 30B Drug Pricing Program.”